Full-Service CRO Services

As a trusted partner in clinical research, ProPharma brings 20+ years of expertise, seamlessly integrating with your team to turn scientific breakthroughs into life-changing therapies.

Business worker working around a conference table

Customizable, Scalable, Strategy-Led, Global Contract Research Organization Services

Sponsors aim to move their products from development to commercialization as quickly and efficiently as possible. Traditionally, biotech, pharma, and MedTech companies have relied on the hope that the science will succeed and that a standard contract research organization (CRO) model will get them to the finish line. However, with the evolving landscape, there's now a need for more personalization and agility—something that rigid CRO models typically don't offer.

CRO Services

ProPharma stands at the forefront of the contract research organization industry, offering a comprehensive suite of services that span the entire drug, device and diagnostics development lifecycle. As a full-service CRO, ProPharma excels in providing end-to-end solutions, from early research to post-marketing surveillance. Our expertise encompasses Phase I-IV clinical research, regulatory sciences, pharmacovigilance, and quality assurance, ensuring that each project meets the highest standards of quality and compliance.

Pins holding up multi colored string

Key Criteria for Selecting a CRO

When selecting a CRO, it is essential to consider several factors:

Innovation icon

Expertise and Experience

The CRO should have a proven track record in the therapeutic area relevant to the drug being developed. This includes expertise in handling complex development processes, particularly for biologics and cell and gene therapies.

Quality & Compliance icon

Quality Assurance and Regulatory Compliance

Ensure the CRO adheres to high standards of quality and compliance with regulatory requirements such as Good Laboratory Practice (GLP) and Good Clinical Practice (GCP).

Full Service Clinical Trials icon

Comprehensive CRO Service Offerings

A top contract research organization or CRO should offer a broad range of services that cover the entire drug development lifecycle, from early studies to post-marketing surveillance.

Program and project management icon

Tailored Solutions

The ability to provide customized solutions that fit the unique needs of each project is crucial for ensuring optimal outcomes.

ProPharma: Full-Service CRO

Several business professionals talking around glass conference table

Full-Service CRO Capabilities

ProPharma’s client-focused approach ensures that every project benefits from our commitment to quality, innovation, and strategic consulting. Our dedication to improving patient health and safety drives their mission to deliver the technologies, medicines, and therapies of tomorrow.

ProPharma’s global reach and scalable solutions make us a reliable partner for both small startups and large pharmaceutical companies. By emphasizing strategic partnerships and bespoke solutions, ProPharma ensures that each client receives the support and expertise needed to navigate the complexities of drug and device development.

Hand wearing latex gloves writing on clipboard near medical equipment

Industry-Leading Support for Multiphase Clinical Development and Study Execution

ProPharma is a global provider of patient-focused clinical research solutions to the pharmaceutical, biotechnology, and medical device and diagnostic industries. We are experts, with experience across all study phases and in a diverse and wide range of therapeutic areas. Our shared attributes of innovation, expertise, and passion are at the heart of everything we do.

Medical device icon

Early Phase (Phase 1-2)

Early Phase (Phase 1-2)

Regulatory CMC icon

Late Phase (Phase 3 and Beyond)

Late Phase (Phase 3 and Beyond)

Safety systems icon

Medical Device & Diagnostics

Medical Device & Diagnostics

Early Phase (Phase 1-2) CRO Services

Quick completion of Phase 1-2 trials to meet proof of concept goals is critical. We provide clinical expertise and an extended suite of early phase clinical development services specifically engineered to accelerate study progression.

Our integrated regulatory, pharmacology, statistics, and clinical experts design protocols that address and generate the data you need to make go and no-go decisions.

health-care-worker-with-latex-gloves-typing-on-keyboard-ss-1322036018-650x425

Late Phase (Phase 3 and Beyond)

We can develop and execute the global plans to move you forward – from reviewing and managing ongoing efficacy and safety data to generating real-world evidence to support pricing agreements. Our regulatory, clinical, and medical affairs experts know what you need. We are committed to delivering the strategy and market solutions you need to be successful.

Row of lab techs wearing protective equipment working on various medical devices

Medical Device & Diagnostics

ProPharma has a unique combination of experience across the Medical Device Trial Space that drives the successful conduct of Medical Device and Diagnostic study. Our staff offers extensive experience in conducting First in Human/Feasibility, Pilot, Pivotal, and Post-Market Approval Studies.

Within the device trial space, our experience ranges across several medical device research trials including but not limited to:

  • Various cardiovascular trials, particularly in surgical settings
  • Urology devices
  • Orthopedic devices
  • Intravascular renal system devices
  • Respiratory treatment devices
  • Hemostatic devices

This experience spans across all functional areas – from operationalizing the trial at the study site level to managing the data through data management and analyzing the data through Biostatistics. We are well-versed in the data that is collected and summarized within device studies.

healthcare-provider-looking-into-medical-device-ss-618146492-650x425
Gradient Image

Your Partner in Clinical Research

ProPharma offers a wide range of CRO services designed to support clients throughout the drug development process.

Comprehensive, Full-Service CRO Offerings and Services

clinicalResearch

Clinical Research Solutions

Comprehensive management of clinical trials, including site selection, patient recruitment, data management, and biostatistics.

Clinical Research Solutions

Comprehensive management of clinical trials, including site selection, patient recruitment, data management, and biostatistics.

Read Less
Soluitons Icons

Regulatory Sciences

Expertise in navigating the complex regulatory landscape, including preparing and submitting regulatory documents, ensuring compliance, and managing interactions with regulatory...

Read More

Regulatory Sciences

Expertise in navigating the complex regulatory landscape, including preparing and submitting regulatory documents, ensuring compliance, and managing interactions with regulatory authorities.

Read Less
RandD

Research & Development

ProPharma's R&D Technology team offers a full range of strategic and technical consulting services, including technology road-mapping, digital blueprints, system integration,...

Read More

Research & Development

ProPharma's R&D Technology team offers a full range of strategic and technical consulting services, including technology road-mapping, digital blueprints, system integration, data migration, clinical system selection, implementation and validation, and post-production support.

Read Less
Quality

Quality & Compliance

Implementing and maintaining robust quality management systems to ensure the highest standards of compliance and quality.

Quality & Compliance

Implementing and maintaining robust quality management systems to ensure the highest standards of compliance and quality.

Read Less
PharmaC

Pharmacovigilance

Monitoring and reporting adverse events, ensuring patient safety, and maintaining compliance with regulatory requirements.

Pharmacovigilance

Monitoring and reporting adverse events, ensuring patient safety, and maintaining compliance with regulatory requirements.

Read Less
MedicalInformation

Medical Information

Providing accurate and timely medical information to support healthcare professionals and patients.

Medical Information

Providing accurate and timely medical information to support healthcare professionals and patients.

Read Less
Business professionals smiling at a desk reviewing data

Full-Service CRO Solutions

Get Expert Guidance for your Clinical Development Needs

ProPharma’s comprehensive CRO service offerings and strategic approach enables pharmaceutical, biotechnology, medical device and diagnostics companies to bring new drugs and therapies to market efficiently and effectively.

As a full-service contract research organization, ProPharma connects your clinical aspirations with our deep scientific and medical expertise, strong therapeutic insights, and unmatched clinical development experience to help you bring high-quality therapies to market fast – always with the patients’ safety in mind.

Our dedication to client success, quality, and innovation, we ensure that each project is tailored to meet specific needs, resulting in optimal outcomes and a higher probability of success.

Business people analyzing and planning

Oncology CRO

As a CRO, we've led more than 60 oncology and hematology studies across 30+ indications, giving us deep insight into the complexities of cancer research. From adaptive trial design to global site engagement and regulatory navigation, we deliver speed and certainty across every phase of development.

Obesity CRO

Our CRO team brings proven success in managing obesity trials, where patient recruitment, retention, and engagement are critical. We combine decentralized models, creative consent strategies, and real-world evidence integration to help clients advance innovative treatments with confidence.

What is a CRO?

Contract Research Organizations (CROs), sometimes referred to as Clinical Research Organizations, provide specialized research services to pharmaceutical, biotechnology and medtech companies. These organizations support the development and approval of new drugs and medical devices through a wide range of services, including clinical research, data management, regulatory affairs, and quality assurance.

Importance of CROs in Drug Development

CROs play a crucial role in drug development by offering cost-effective and time-efficient services compared to in-house research. They provide expertise across various stages of drug development, from early-stage laboratory research to late-stage clinical trials. For emerging pharmaceutical, biotech, and medical device organizations, CROs can significantly reduce the time and expense involved in bringing a new drug to market.

What is a CRO?

Contract Research Organizations (CROs), sometimes referred to as Clinical Research Organizations, provide specialized research services to pharmaceutical, biotechnology and medtech companies. These organizations support the development and approval of new drugs and medical devices through a wide range of services, including clinical research, data management, regulatory affairs, and quality assurance.

Importance of CROs in Drug Development

CROs play a crucial role in drug development by offering cost-effective and time-efficient services compared to in-house research. They provide expertise across various stages of drug development, from early-stage laboratory research to late-stage clinical trials. For emerging pharmaceutical, biotech, and medical device organizations, CROs can significantly reduce the time and expense involved in bringing a new drug to market.

Featured CRO Articles

Pros and Cons of Working with a CRO

Pros and Cons of Working with a CRO

A Contract Research Organization (CRO) is a company that provides support to the pharmaceutical, biotechnology, and medical device industries in the form of research services outsourced on a contract...

7 Things to Consider Before Selecting a CRO

7 Things to Consider Before Selecting a CRO

Selecting the right contract research organization (CRO) is one of the most important decisions you, as a sponsor, must make. That’s because CROs can improve efficiency and increase productivity,...

Enhancing CRO Capabilities with Independent Physician Services

Enhancing CRO Capabilities with Independent Physician Services

The involvement of Medical Monitoring (MM) and Data Safety Monitoring Boards (DSMB) in trials has been somewhat unknown to individuals outside of clinical circles. That is, until media attention...

News & Insights

Medical Information in the Netherlands: Safeguarding Compliance and Patient Confidence

October 2, 2025

Medical Information in the Netherlands: Safeguarding Compliance and Patient Conf...

Discover how ProPharma's medical information services in the Netherlands ensure patient safety, regulatory compliance, and data privacy with expert support.

Tips for Preparing Successful FDA 510(k) Submissions

September 30, 2025

Tips for Preparing Successful FDA 510(k) Submissions

Discover essential tips for preparing a successful FDA 510(k) submission. Learn common pitfalls to avoid, align with FDA expectations, and streamline your path to clearance.

FDA’s Crackdown on Drug Advertising: Key Lessons from 60 Compliance Letters in 2025

September 26, 2025

FDA’s Crackdown on Drug Advertising: Key Lessons from 60 Compliance Letters in 2...

Insights from FDA’s latest round of compliance letters which indicates a major shift in ad promo oversight revealing new compliance risks for Sponsors.

ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice President, Labeling & Strategy to Advance Strategic Labeling & Promotional Review

July 8, 2025

ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice Presid...

ProPharma appoints former FDA labeling expert as VP, Labeling & Strategy, enhancing strategic labeling, promotional review, and regulatory consulting expertise to accelerate drug development and...

ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Appoints Brian Tuttle as Chief Financial Officer

October 21, 2024

ProPharma Appoints Brian Tuttle as Chief Financial Officer

ProPharma appoints Brian Tuttle as CFO to drive financial strategy and accelerate global growth, leveraging his 20 years of life sciences industry experience.

ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

Case Study Critical Database Lock Milestone Achieved Through Rapid FSP Support for BioXcel Therapeutics, Inc. - ProPharma

October 6, 2025

Critical Database Lock Milestone Achieved Through Rapid FSP Support for BioXcel ...

When BioXcel Therapeutics’ pivotal Phase 3 study faced a critical slowdown, timelines and regulatory goals were at risk. With their primary CRO unable to meet growing demands, ProPharma stepped in —...

Whitepapers Your Complete FDA 510(k) Premarket Notification Checklist

September 30, 2025

Your Complete FDA 510(k) Premarket Notification Checklist

Step-by-step guide to navigating the FDA 510(k) submission process with confidence Submitting a 510(k) premarket notification is a critical milestone for medical device manufacturers seeking U.S....

Infographic Unannounced FDA Inspections Without Borders - ProPharma

September 19, 2025

Unannounced FDA Inspections Without Borders

Unannounced FDA inspections are no longer limited to the U.S. — they’re expanding globally. Starting in 2025, foreign sites will face the same surprise visits and public scrutiny as U.S. facilities,...

Navigating the New EU HTA Regulation as an MAH: Strategic Insights for Successful JCA Submissions

November 18, 2025

Navigating the New EU HTA Regulation as an MAH: Strategic Insights for Successful JCA Submissions

Explore how the new EU HTA Regulation (EU HTAR) is transforming market access across Europe. Join our expert to learn practical strategies for successful Joint Clinical Assessment (JCA) submissions,...

AI in Medical Information: Who Holds the Responsibility?

October 16, 2025

AI in Medical Information: Who Holds the Responsibility?

In Medical Information (MI) and beyond, key questions arise: Who ensures accuracy, compliance, and ethical use — individual contributors, leadership, pharma clients, or technology providers? And what...

Improving Patient Health and Safety through Pharmacovigilance and Medical Information Synergy

September 25, 2025

Improving Patient Health and Safety through Pharmacovigilance and Medical Information Synergy

Medical Information (MI) and Pharmacovigilance (PV) work together to protect public health by identifying and evaluating emerging safety signals. Watch our in-depth webinar, where our experts explore...

News & Insights

Medical Information in the Netherlands: Safeguarding Compliance and Patient Confidence

October 2, 2025

Medical Information in the Netherlands: Safeguarding Compliance and Patient Conf...

Discover how ProPharma's medical information services in the Netherlands ensure patient safety, regulatory compliance, and data privacy with expert support.

Tips for Preparing Successful FDA 510(k) Submissions

September 30, 2025

Tips for Preparing Successful FDA 510(k) Submissions

Discover essential tips for preparing a successful FDA 510(k) submission. Learn common pitfalls to avoid, align with FDA expectations, and streamline your path to clearance.

FDA’s Crackdown on Drug Advertising: Key Lessons from 60 Compliance Letters in 2025

September 26, 2025

FDA’s Crackdown on Drug Advertising: Key Lessons from 60 Compliance Letters in 2...

Insights from FDA’s latest round of compliance letters which indicates a major shift in ad promo oversight revealing new compliance risks for Sponsors.

Previous Post Arrow Next Post Arrow
ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice President, Labeling & Strategy to Advance Strategic Labeling & Promotional Review

July 8, 2025

ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice Presid...

ProPharma appoints former FDA labeling expert as VP, Labeling & Strategy, enhancing strategic labeling, promotional review, and regulatory consulting expertise to accelerate drug development and...

ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Appoints Brian Tuttle as Chief Financial Officer

October 21, 2024

ProPharma Appoints Brian Tuttle as Chief Financial Officer

ProPharma appoints Brian Tuttle as CFO to drive financial strategy and accelerate global growth, leveraging his 20 years of life sciences industry experience.

Previous Post Arrow Next Post Arrow
ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

Previous Award Arrow Next Award Arrow
Case Study Critical Database Lock Milestone Achieved Through Rapid FSP Support for BioXcel Therapeutics, Inc. - ProPharma

October 6, 2025

Critical Database Lock Milestone Achieved Through Rapid FSP Support for BioXcel ...

When BioXcel Therapeutics’ pivotal Phase 3 study faced a critical slowdown, timelines and regulatory goals were at risk. With their primary CRO unable to meet growing demands, ProPharma stepped in —...

Whitepapers Your Complete FDA 510(k) Premarket Notification Checklist

September 30, 2025

Your Complete FDA 510(k) Premarket Notification Checklist

Step-by-step guide to navigating the FDA 510(k) submission process with confidence Submitting a 510(k) premarket notification is a critical milestone for medical device manufacturers seeking U.S....

Infographic Unannounced FDA Inspections Without Borders - ProPharma

September 19, 2025

Unannounced FDA Inspections Without Borders

Unannounced FDA inspections are no longer limited to the U.S. — they’re expanding globally. Starting in 2025, foreign sites will face the same surprise visits and public scrutiny as U.S. facilities,...

Previous Resource Arrow Next Resource Arrow
Navigating the New EU HTA Regulation as an MAH: Strategic Insights for Successful JCA Submissions

November 18, 2025

Navigating the New EU HTA Regulation as an MAH: Strategic Insights for Successful JCA Submissions

Explore how the new EU HTA Regulation (EU HTAR) is transforming market access across Europe. Join our expert to learn practical strategies for successful Joint Clinical Assessment (JCA) submissions,...

AI in Medical Information: Who Holds the Responsibility?

October 16, 2025

AI in Medical Information: Who Holds the Responsibility?

In Medical Information (MI) and beyond, key questions arise: Who ensures accuracy, compliance, and ethical use — individual contributors, leadership, pharma clients, or technology providers? And what...

Improving Patient Health and Safety through Pharmacovigilance and Medical Information Synergy

September 25, 2025

Improving Patient Health and Safety through Pharmacovigilance and Medical Information Synergy

Medical Information (MI) and Pharmacovigilance (PV) work together to protect public health by identifying and evaluating emerging safety signals. Watch our in-depth webinar, where our experts explore...

Previous Webinar Arrow Next Webinar Arrow